Crystalloid Solutions

01/01/2019 - "The first line treatment for hypotension in preterm infants is volume expansion with crystalloid solutions, but this has limited efficacy in the preterm infant. "
10/01/1994 - "In our series, hypotension responded well to i.v. crystalloid fluid administration. "
07/01/2022 - "This study compared the occurrence of postinduction hypotension and changes in cardiac dynamic indices in patients with and without crystalloid preloading undergoing decompressive cervical spine surgery. "
01/01/2020 - "Crystalloid versus control (no fluids) Fewer women experienced hypotension in the crystalloid group compared with no fluids (average risk ratio (RR) 0.84, 95% confidence interval (CI) 0.72 to 0.98; 370 women; 5 studies; low-quality evidence). "
01/01/2017 - "Crystalloid versus control (no fluids)Fewer women experienced hypotension in the crystalloid group compared with no fluids (average risk ratio (RR) 0.84, 95% confidence interval (CI) 0.72 to 0.98; 370 women; 5 studies; low-quality evidence). "

01/01/2014 - "The administration of crystalloid fluids is considered as the first line treatment in management of trauma patients. "
02/01/2011 - "This study examines the threshold crystalloid volume that is an independent risk factor for mortality after trauma. "
01/01/2001 - "To study the volume effect of isotonic and hypertonic crystalloid fluid during ambulance transports after mild trauma, a prospective case-control study was initiated, using the ambulance and helicopter transport system in Stockholm. "
07/01/1989 - "The study demonstrates that a significant drop in hematocrit may be expected in nonbleeding patients who receive crystalloid infusions during trauma evaluation protocols."
11/08/2023 - "We conducted a two-part pilot randomized controlled trial (RCT) comparing liberal to restricted crystalloid fluid management in 50 pediatric post-operative (1-18 years) and trauma (1-15 years) patients admitted to our pediatric intensive care unit (PICU). "

01/01/2011 - "The aim of this study was to compare, in a controlled volume-driven porcine model of hemorrhagic shock, the effects of three different crystalloid solutions on the hemodynamics and acid-base balance. "
10/24/2023 - "Effects of Different Crystalloid Fluids on Renal Tissue in an Experimental Model of Hemorrhagic Shock."
01/01/2023 - "Our objective was to determine the prehospital crystalloid volume associated with the lowest mortality among patients in hemorrhagic shock. "
02/01/2022 - "The AAJT may therefore be considered in a situation of hemorrhagic shock to limit the need for crystalloid infusions, although removal of the AAJT caused more severe hemodynamic and metabolic effects which required vasopressor support."
02/01/2017 - "Several kinds of crystalloid solutions have been used in the treatment of hemorrhagic shock (HS). "

01/01/2018 - "Prospective randomized single-center trial of fast (5-10 minutes) versus slow (20-30 minutes) administration of 500ml balanced crystalloid FC in spinal surgery (cohort OR) and septic shock (cohort SEP) patients. "
01/01/2022 - "Despite this uncertainty, CMS continues to recommend that 30 ml/kg of an intravenous crystalloid solution be administered to patients in septic shock starting within 3 h of presentation. "
02/01/2020 - "Prospective observational study including 35 patients with septic shock in which rPP and cardiac output were measured before and after a fluid challenge with 400 mL of crystalloid solution. "
01/01/2019 - "Crystalloid infusion (≥30 mL/kg) within 6 h of identification of septic shock as required by CMS. "
06/01/2005 - "We investigated the systemic and regional hemodynamic effects of early crystalloid infusion in an experimental model of septic shock induced by intravenous inoculation with live Escherichia coli. "

08/01/2012 - "The data of this study indicate that the extracorporal perfusion of muscle flaps with crystalloid fluid is a possible protective strategy against ischemia. "
05/01/1992 - "In subsequent studies, hearts were subjected to 20 minutes of aerobic perfusion (coronary flow, 2.0 +/- 0.3 ml/min/gm wet weight in blood-perfused hearts versus 11.3 +/- 3.0 ml/min/gm wet weight in crystalloid-perfused hearts; left ventricular developed pressure, 90 +/- 4 and 91 +/- 2 mm Hg, respectively) followed by 30, 45, 60, 75, 90, or 105 minutes of normothermic global ischemia and 40 minutes of reperfusion (n = 4 per group). "
05/01/2010 - "At the end of renal ischemia time, both groups had received approximately 3 L crystalloid solution. "
04/01/2010 - "Isolated, crystalloid perfused working hearts were subjected to 30 min of global normothermic ischemia followed by 15 min of reperfusion; functional recovery was then measured in the two groups. "
06/01/2005 - "Following hypothermic global ischemia, hearts were crystalloid reperfused in a four-chamber isolated working mode. "